In the study by Navines et al. (2022), patients with high baseline S100B levels significantly improved Montgomery Åsberg Depression Rating Scale scores compared to those with low S100B levels during pharmacotherapy with escitalopram or sertraline [79]. The gene discussed is S100B; the disease is depressive disorder.